These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34126574)

  • 1. Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer's disease.
    Zhang C; Lv Y; Bai R; Xie Y
    Bioorg Chem; 2021 Sep; 114():105070. PubMed ID: 34126574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
    Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.
    Mzezewa SC; Omoruyi SI; Zondagh LS; Malan SF; Ekpo OE; Joubert J
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1607-1621. PubMed ID: 34281458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
    Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
    J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
    Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
    Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity.
    Mi Z; Gan B; Yu S; Guo J; Zhang C; Jiang X; Zhou T; Su J; Bai R; Xie Y
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1489-1497. PubMed ID: 31416364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
    Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y
    Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer's disease.
    Liu Z; Shi Y; Zhang X; Yu G; Li J; Cong S; Deng Y
    Bioorg Med Chem; 2022 Mar; 58():116660. PubMed ID: 35183029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease.
    Jiang X; Guo J; Zhang C; Gu J; Zhou T; Bai R; Xie Y
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2045-2054. PubMed ID: 34607518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets.
    Purgatorio R; Kulikova LN; Pisani L; Catto M; de Candia M; Carrieri A; Cellamare S; De Palma A; Beloglazkin AA; Reza Raesi G; Voskressensky LG; Altomare CD
    ChemMedChem; 2020 Oct; 15(20):1947-1955. PubMed ID: 32716595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of MAO-B inhibitors - present status and future directions part I: oxygen heterocycles and analogs.
    Helguera AM; Perez-Machado G; Cordeiro MN; Borges F
    Mini Rev Med Chem; 2012 Sep; 12(10):907-19. PubMed ID: 22420569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
    Li F; Wu JJ; Wang J; Yang XL; Cai P; Liu QH; Kong LY; Wang XB
    Bioorg Med Chem; 2017 Jul; 25(14):3815-3826. PubMed ID: 28549891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
    Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
    Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs.
    Gnerre C; Catto M; Leonetti F; Weber P; Carrupt PA; Altomare C; Carotti A; Testa B
    J Med Chem; 2000 Dec; 43(25):4747-58. PubMed ID: 11123983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
    Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
    Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
    Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.